Compounds > lonafarnib
Page last updated: 2024-09-04

lonafarnib and HIV Coinfection

lonafarnib has been researched along with HIV Coinfection in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Apelian, D; Bozdayi, AM; Çalişkan, A; Choong, I; Glenn, JS; Heller, T; Idilman, R; Kalkan, Ç; Karakaya, F; Karatayli, E; Karatayli, S; Keskin, O; Koh, C; Önem, S; Yurdaydin, C; Yurdcu, E1
Barreiro, P; Sherman, KE; Soriano, V1

Reviews

1 review(s) available for lonafarnib and HIV Coinfection

ArticleYear
Hepatitis delta and HIV infection.
    AIDS (London, England), 2017, 04-24, Volume: 31, Issue:7

    Topics: Antiviral Agents; Disease Transmission, Infectious; Hepatitis D, Chronic; HIV Infections; Humans; Interferon-alpha; Lipopeptides; Liver Cirrhosis; Liver Neoplasms; Piperidines; Pyridines; Sustained Virologic Response

2017

Trials

1 trial(s) available for lonafarnib and HIV Coinfection

ArticleYear
A phase 2 dose-finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis.
    Hepatology (Baltimore, Md.), 2022, Volume: 75, Issue:6

    Topics: Alanine Transaminase; Drug Therapy, Combination; Hepatitis D, Chronic; HIV Infections; Humans; Interferon-alpha; Piperidines; Pyridines; Ritonavir; RNA

2022